Copyright
©The Author(s) 2021.
World J Psychiatr. Jul 19, 2021; 11(7): 355-364
Published online Jul 19, 2021. doi: 10.5498/wjp.v11.i7.355
Published online Jul 19, 2021. doi: 10.5498/wjp.v11.i7.355
Year | Major Advances |
1950 | Synthesis of chlorpromazine[3] |
1952 | Preliminary evidence of antipsychotic effect of chlorpromazine[6,7,11] |
1958 | Synthesis of haloperidol[16] |
1960 | Parkinson basal ganglia are deficient in dopamine[19] |
1963 | Neuroleptics raise level of monoamine metabolites[18] |
1966 | Neuroleptics may antagonize dopamine receptors[26] |
1971 | 2 nmol haloperidol in plasma effective in psychosis[34] |
1974 | Synthesis of (+-) butaclamol[36] |
1975 | Tritiated haloperidol binds DA receptors[38] |
1975 | Effective neuroleptic dose correlates with D2 block[39] |
1979 | Multiple dopamine receptors[54] |
1984 | Bimodal D2 distribution in schizophrenia[45] |
1984 | High and low affinity states for D2[58] |
1988 | Cloning of the D2 receptor[63] |
1988 | In vivo imaging of D2 occupancy[47] |
1990 | Cloning of D3[67] |
1999 | Fast-off theory[71] |
2000 | Multiple genetic variants of D2 receptor[73-75] |
2000 | Impact of the D3 receptor[81] |
2005 | Impact of other neurotransmitter receptors[83] |
2010 | Impact of receptor heterodimers[85] |
2017 | Impact of D2 high affinity state[77] |
2021 | Structure and specificities of D1, D2 signaling complexes[79] |
- Citation: Seeman MV. History of the dopamine hypothesis of antipsychotic action. World J Psychiatr 2021; 11(7): 355-364
- URL: https://www.wjgnet.com/2220-3206/full/v11/i7/355.htm
- DOI: https://dx.doi.org/10.5498/wjp.v11.i7.355